|
|
Drug
companies- helping or harming the health of the Third
World? This month we review a controversial study of
the issue- and a round up of books on the Bomb.
Editor:
Anuradha Vittachi
|
The
quick fix
The
Health of Nations: a North-South Investigation
by by Mike Muller

Faber
pbk £3.95

 |
| Illustration: Clive
Offley |
|
|
In
August 1979 a woman living in Mozambique took a pain-killing
drug. It was sold by a well-known transnational
company, manufactured according to the latest hygienic methods
and contained what the label described. The effects, however,
were frightening. A painful infection erupted all over her face
and spread to other parts of the body. Abscesses formed in her
lungs. Her life was in danger and was saved only by emergency
action when she was flown to a hospital in South Africa It was
later discovered that the drug had been shown liable to cause
such side-effects 58 years before. In
The Health of Nations, Mike Muller asks whether the positive
contributions made by transnational drug companies are not ‘outweighed
by, and incidental to, the damage they do and the bad health
they promote: in economic terms, whether the resources they
have captured would not generate more benefit to their consumers
if
applied in other ways'.
In
the early 1970s there was only a handful of relevant studies
of these companies; now there is a deluge. Issues like drug
safety, efficacy, research, market power and drug use are
discussed in
the first half of Muller’s book. All are legitimate
targets for critics of the large companies.
More
pertinent, however, is questioning the nature of health itself.
Now the fashionable catch-phrases are ‘Health by
the People’ and ‘Health for all by the Year 2000’.
The emphasis is changing from curative to preventative
medicine and, thus, away from pharmaceuticals.
Not
surprisingly, the drug companies are eager to find a role for
themselves in this new environment or, better
still,
to
control any change. The second half of the book discusses
the position
in the 1980s: the concerted attack by UN agencies on
bad health — and
the corporate response. Muller’s information is
up to date and his references as diverse as the Dar es
Salaam Daily News,
and documents produced by the transnationals for internal
use.
Muller
is an excellent person to tackle this subject He writes very
readably and is no stranger to health
controversies:
in the early 1970s he wrote the influential War on
Want book,
The Baby Killer Scandal, and followed it with Tomorrow’s
Epidemic, an examination of tobacco marketing in the
Third World.
Today
he works as an engineer in Beira, Mozambique. He has seen at
first hand the effects of drug usage
in the
Third
World and
has the ability to set the particular against an
international background. The woman described in the first
paragraph
called on him for emergency help and the book is
full of such incidents
observed in several countries.
And
the other end of the chain has not been ignored. Muller has
interviewed the decision makers of the
big companies
in their
headquarters and presents a fascinating account
of the strategies they now adopt to meet their critics.
If
there is a failing in this book, it is in the oversimplification
of the political economy. Mention
is made of the vested
interests of medical doctors but in countries
such as India, frequently
praised for its capacity to produce pharmaceuticals,
there are other issues. Local production is-promoted
not so much
for medical
considerations as for the economic targets of
import substitution and the elusive benefits of industrialisation.
Recent studies
of India suggest that such schizophrenic planning
is, at best, irrelevant to the health of the
general
population.
Although
Muller is able to describe some positive recent developments,
the mood of the book is
pessimistic. ‘The multinational
companies have a positive contribution to make to Third World
health care: of this there can be no doubt,’ he say-s.
The problem is that they are not making that contribution. ‘After
all,’ says a spokesman for the pharmaceutical transnationals, ‘you
can’t expect us to support policies which run counter to
our own interests.’
Andrew
Stoker

Andrew
Stoker has worked as a chemical engineer in a major
pharmaceutical company and is currently with the University
of Edinburgh, U.K.

Anti-nuclear
roundup
The
Politics of Uranium is an inadequate title for this book by Norman
Moss (Andre Deutsch, £4.95). It does, to be sure, deal
with the politics of nuclear power and nuclear weapons, and with
the economics and trade that are linked with the politics. But
it deals with so much else besides: the structure of matter;
radioactivity; the invention of the fission and fusion processes;
chain reactions and the manufacture of plutonium; efforts at
control; where and how uranium is mined; the nuclear non-proliferation
treaty; how the various types of nuclear reactor work; the disposal
of nuclear waste; the dangers of radiation.
All
these and more are dealt with in close packed, factual prose.
The readers are left to pass their own judgement and to supply
their own indignation.
But
The Politics of Uranium stops short of discussing the possible
use of The Bomb (it’s strange how everyone knows what is
meant by ‘The Bomb’ and ‘The Pill’,
as distinct from any other bombs or pills). For that, one
needs
to choose among the plethora of books and pamphlets that
have appeared over the last couple of years, some with an
international
appeal, others primarily directed towards a readership in
a particular country.
Among
the best of the former is Nigel Calder’s Nuclear
Nightmares; an Investigation into Possible Wars (Penguin £1.50,
53.95)— not a book to cheer one up. Calder says, ‘The
risk of a holocaust is growing with every year that passes and
whether we shall avoid it between now and 1990 is at least questionable.’
Of
the many directed primarily towards British readers (slingstones
of David against the Goliath of the official
line and its
supporters), my own preferences are How to Make
up Your Mind about the Bomb by Robert Neild (Andre Deutsch, £2.95) and Nuclear
Weapons: the Way Ahead by Ronald Gaskell (Menard Press, £1.20).
These
serve to ‘educate our anger’, to take the Rev.
Sloan Coffin’s phrase when addressing the World Council
of Churches conference at Amsterdam last year. But first must
come the anger that is to be educated. To that end I’ve
recently reread John Hersey’ s Hiroshima* (Penguin Classics £1.10)— over
thirty years old but nothing published since can match
it.
David
Pitt
(*For
a fuller review of ‘Hiroshima’, see NI
113 classic) |